Condition
IMT
Total Trials
4
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05160922Phase 4Active Not Recruiting
Crizotinib Continuation Clinical Study
NCT05540054Not ApplicableCompleted
Inspiratory Muscle Training Efficiency Before Bronchoscopic Procedure
NCT02127333Completed
Role of Oxygen for Vascular Dysfunction
NCT01862146Completed
Arterial Remodeling in Smokers
Showing all 4 trials